Categories: EHRHealthcareNews

JardogsHealth Earns 2026 Frost & Sullivan Enabling Technology Leadership Recognition

Recognition highlights deep EHR integration, physician-centered design, and clinician-led development in the North American AI clinical workflow automation market

HILLSBORO, Ill., Sept. 16, 2026 /PRNewswire/ — JardogsHealth, the AI operating layer for healthcare and the company behind MyMedicalScribe, today announced it has earned Frost & Sullivan’s 2026 Enabling Technology Leadership Recognition in the North American AI clinical workflow automation market.

The recognition identifies companies that apply technology in new ways to improve existing products and services while elevating the customer experience. Following its evaluation, Frost & Sullivan recognized JardogsHealth for its approach to clinical workflow automation, including deep EHR integration, physician-centered design, specialty-specific documentation, and product development conducted in direct partnership with practicing clinicians.

The recognition comes as healthcare organizations increasingly turn to AI to address mounting workflow inefficiencies and physician burnout. Frost & Sullivan identifies ambient clinical documentation and workflow automation as the fastest-growing segment of the market, while noting that incomplete EHR integration, limited customization, and specialty-specific documentation gaps continue to create barriers to adoption.

In its analysis, Frost & Sullivan highlighted a foundational principle behind JardogsHealth’s approach: integrating AI into broken EHR workflows produces broken AI. Rather than adding AI as another layer on top of existing documentation burdens, JardogsHealth has rebuilt the clinical workflow with AI as the organizing logic.

The technical foundation of that approach includes deep, bidirectional integration with major EHR platforms, allowing JardogsHealth to bring patient context into the workflow and return completed work to the systems healthcare organizations already use. Frost & Sullivan noted that the resulting experience allows technology to conform to the way physicians practice rather than requiring physicians to change how they work.

“JardogsHealth’s creative differentiation lies in identifying an underserved white space that the healthcare technology industry has consistently failed to occupy: a clinical documentation experience that physicians want to use,” shares Ana Dominguez, Best Practices Industry Analyst, Frost & Sullivan.

Frost & Sullivan also pointed to real-world physician adoption as evidence of that approach. At Springfield Clinic, JardogsHealth expanded from an initial pilot of approximately five physicians to more than 600 active users, growth the analysis attributes largely to physician-to-physician advocacy.

The report further recognized JardogsHealth’s development model, which brings practicing physicians and healthcare teams directly into the product development process. By building alongside the people who use the technology, JardogsHealth is able to identify and address clinical and administrative needs before broader deployment rather than asking healthcare organizations to adapt their workflows around the technology.

“Physicians didn’t need another AI tool bolted onto the EHR. They needed the workflow itself to work,” said Jim Hewitt, Chief Executive Officer of JardogsHealth. “We built this alongside the clinicians who use it every day, and this recognition reflects their fingerprints as much as ours.”

While clinical documentation is central to Frost & Sullivan’s analysis, JardogsHealth’s vision extends beyond the documentation experience. The company has built an AI operating layer designed to connect intelligence, automation, and action across healthcare while extending, rather than replacing, the EHR as the system of record.

“JardogsHealth has distinguished itself in the AI clinical workflow automation market by addressing the foundational failure that has limited the impact of ambient AI tools across healthcare: the inability to integrate meaningfully into the clinical workflows physicians use,” said Tanuja Sahay, Research Director, Healthcare IT at Frost & Sullivan. 

Frost & Sullivan concluded that JardogsHealth’s combination of native EHR integration, clinician-led product development, and physician-driven adoption has created a platform capable of delivering immediate, measurable value without requiring physicians to change how they practice.

Read the full Frost & Sullivan report now on JardogsHealth.com.

About JardogsHealth

JardogsHealth is the AI operating layer for healthcare. Its Care Platform connects intelligence, automation, and action across healthcare workflows while extending the EHR as the system of record. Built by healthcare technology leaders and developed alongside practicing clinicians, JardogsHealth brings together clinical intelligence, patient experience, and operational and revenue intelligence in one connected platform. Learn more at JardogsHealth, and follow JardogsHealth on LinkedIn.

About the Frost & Sullivan Award

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.

View original content to download multimedia:https://www.prnewswire.com/news-releases/jardogshealth-earns-2026-frost–sullivan-enabling-technology-leadership-recognition-302879692.html

SOURCE JardogsHealth

Staff

Recent Posts

PRC Pairs Workforce Wellbeing Measurement With Frontline Workshops in AP3-Exclusive Package

PRC named a preferred employee experience survey and solutions provider within the ASHHRA Preferred Partner…

7 hours ago

Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026

DENVER, CO / ACCESS Newswire / September 16, 2026 / Aytu BioPharma, Inc. (the "Company"…

10 hours ago

FlexXray Releases Third Annual Benchmark Report on Foreign Material Contamination in Food Manufacturing

ARLINGTON, Texas, Sept. 16, 2026 /PRNewswire/ -- FlexXray, the leader in foreign material inspection services…

13 hours ago

Investors pour over $30bn into longevity biotech as report predicts longevity drugs from 2035

Longevity Biotech Report forecasts a $617bn market by 2045.LONDON, Sept. 16, 2026 /PRNewswire/ -- Global…

13 hours ago

ISPE Announces Keynote Speakers for its 2026 ISPE Pharma 4.0™ and Biopharma Conference

The conference will take place 10–11 December in Berlin, Germany, and virtually.The conference will feature…

13 hours ago

Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI

5.1-fold enrichment using NIH Tox21 data validates structure-based AChE screening as OpenAI and Anthropic highlight…

13 hours ago